// App-Quantinova.ai

491 : Markers of Neutrophil Activation in Patients with ANCA-associated Vasculitis and Large-vessel Vasculitis

Researchers

Presenter

  • Despina Michailidou

Principal Investigators

  • Runa Kuley

  • David Cuthbertson

  • Peter Grayson

  • Nader Khalidi

  • Curry Koening

  • Carol Langford

  • Carol McAlear

  • Larry Moreland

  • Christian Pagnoux

  • Philip Seo

  • Ulrich Specks

  • Antoine Sreih

  • Kenneth J. Warrington

  • Tomas Mustelin

  • Paul Monach

  • Peter Merkel

  • Christian Lood

Medical Centers

  • Division of Medical Oncology, University of Washington, Seattle, WA

  • University of South Florida, Tampa, FL

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

  • Division of Rheumatology, Mc Master University, Ontario, Canada, Ontario, Canada

  • Division of Rheumatology, University of Utah and Salt Lake VAMC, Salt Lake City, UT

  • Cleveland Clinic, Cleveland, OH

  • Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA

  • University of Colorado Hospital, Aurora, CO

  • Division of Gastroenterology, Mount Sinai Hospital, Toronto, Ontario, Canada

  • Johns Hopkins University, Baltimore, MD

  • Mayo Clinic, Rochester, MN

  • VA Boston Healthcare System, Boston, MA

  • University of Pennsylvania, Philadelphia, PA

Locations

  • United Kingdom

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • Wegener's granulomatosis

  • Anti-neutrophil cytoplasmic antibody-associated vasculitis

  • Microscopic polyangiitis

  • Large vessel vasculitis

  • Giant cell arteritis

  • Takayasu arteritis

Biomarkers

  • Proto-oncogene tyrosine-protein kinase ROS

Drug/Treatment

  • Cyclosporine eent

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A